Beihai Gofar Chuanshan Biological Co., Ltd. (SHA:600538)

SHA:600538 Revenue

Beihai Gofar Chuanshan Biological had revenue of 76.89M CNY in the quarter ending June 30, 2026, with 2.36% growth. This brings the company's revenue in the last twelve months to 334.05M, up 5.23% year-over-year. In the year 2025, Beihai Gofar Chuanshan Biological had annual revenue of 328.24M, down -3.59%.

• Revenue (ttm): 334.05M
• Revenue Growth: +5.23%
• P/S Ratio: 8.11
• Revenue / Employee: 762.67K
• Employees: 438
• Market Cap: 2.71B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	328.24M	-12.23M	-3.59%
Dec 31, 2024	340.47M	-28.69M	-7.77%
Dec 31, 2023	369.15M	-90.53M	-19.69%
Dec 31, 2022	459.68M	34.97M	8.23%
Dec 31, 2021	424.72M	157.02M	58.65%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 3, 2026

Data Sources Report a data error